The presence of Pneumocystis jirovecii in critically ill patients with COVID-19
- PMID: 33157150
- PMCID: PMC7609246
- DOI: 10.1016/j.jinf.2020.10.034
The presence of Pneumocystis jirovecii in critically ill patients with COVID-19
Conflict of interest statement
Declaration of Competing Interest The authors declare that they have no competing interests.
Comment on
-
Co-infections in people with COVID-19: a systematic review and meta-analysis.J Infect. 2020 Aug;81(2):266-275. doi: 10.1016/j.jinf.2020.05.046. Epub 2020 May 27. J Infect. 2020. PMID: 32473235 Free PMC article.
References
-
- Schauwvlieghe A.F.A.D., Rijnders B.J.A., Philips N., Verwijs R., Vanderbeke L., Van Tienen C. Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study. Lancet Respir Med. 2018;6:782–792. - PubMed
-
- Alanio A., Hauser P.M., Lagrou K., Melchers W.J., Helweg-Larsen J., Matos O. ECIL guidelines for the diagnosis of Pneumocystis jirovecii pneumonia in patients with haematological malignancies and stem cell transplant recipients. J Antimicrob Chemother. 2016;71:2386–2396. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
